Dimebon Fails in Clinical Trials

March 03, 2010

Pfizer and its partner Medivation have announced the failure of Dimebon in Phase 3 clinical trials. This news, just the latest of several failures, will give more weight to the idea of pushing the reset button for Alzheimer's research.

Posted at 01:52 PM in Treatments | Permalink

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83451d58669e201310f59f992970c

Listed below are links to weblogs that reference Dimebon Fails in Clinical Trials:

You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.

Inclusion of links, advertisements and content generated by others does not imply endorsement. Remember, nothing on this site is meant as a substitute for professional medical advice or for using your own judgment!